ALVO
Alvotech
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IS
$5.87
+9.93%Forward multiples
Based on analyst estimates
- P/E forward
- 39.65x
- P/E 2026E
- —
- P/E 2027E
- 25.85x
- P/E 2028E
- 12.23x
- P/S forward
- 2.85x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -10.94x
- Price / sales
- 4.26x
- Price / cash flow
- -10.54x
Enterprise value
- Enterprise value
- $3.4B
- EV / sales
- 6.92x
- EV / EBITDA
- -2388.46x
- EV / EBIT
- 71.92x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026